| SANTHERA PHARMACEUTICALS |
| Schweiz |
| Gesundheit |
| CH1276028821 / A3EJMQ |
| S3F0 (Frankfurt) |
| FRA:S3F0, ETR:S3F0, S3F0:GR |
| - |
| https://www.santhera.com/ |
|
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating dise..
>Volltext.. |
| 245.07 Mio. EUR |
| 326.06 Mio. EUR |
| 85.28 Mio. EUR |
| -35.5 Mio. EUR |
| -54.4 Mio. EUR |
| -4.22 EUR |
| 108.03 Mio. EUR |
| 24.79 Mio. EUR |
| -38.41 Mio. EUR |
| 0.36 |
| 99.24% |
| -18.44% |
| - |
| - |
| - |
| - |
| SANTHERA |
| 13.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|